Grant: Operating Grant
Université de Sherbrooke
$345,524.00
Role of p62 in human osteoclast and Paget's disease development
EF 2009-10
Résumé
Paget's disease of bone (PDB) is a chronic disorder that can result in enlarged and misshapen bones. The excessive breakdown and formation of bone tissue causes affected bone to weaken - resulting in bone pain, misshapen bones, or fractures. Bone abnormalities are due to an over-activity of the cells that normally keep bones strong and healthy. A genetic mutation identified in many patients with PDB may be the key to discovering what is causing their bones to weaken. We are investigating the effects of this mutation on bone cells. We will study bone cells from precursors present in umbilical cord blood, as well as from blood of patients presenting with Paget's disease of bone. Our studies may then provide a better understanding of bone abnormalities and help in the identification of new therapeutic targets for PDB.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
188276
Name
Roux Sophie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Role of p62 in human osteoclast and Paget's disease development
Programtype2
Operating Grants
Orgnameinp2
Université de Sherbrooke
Cihramount2
$345,524
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Apoptosis; Kinases; Osteoclast; Osteoclast Signaling; P62; Paget'S Disease Of Bone
Abstract
Paget's disease of bone (PDB) is a chronic disorder that can result in enlarged and misshapen bones. The excessive breakdown and formation of bone tissue causes affected bone to weaken - resulting in bone pain, misshapen bones, or fractures. Bone abnormalities are due to an over-activity of the cells that normally keep bones strong and healthy. A genetic mutation identified in many patients with PDB may be the key to discovering what is causing their bones to weaken. We are investigating the effects of this mutation on bone cells. We will study bone cells from precursors present in umbilical cord blood, as well as from blood of patients presenting with Paget's disease of bone. Our studies may then provide a better understanding of bone abnormalities and help in the identification of new therapeutic targets for PDB.
Competitiondate
200909
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Roux, Sophie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $345,524~ $0~